Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Allen K. Bourdon"'
Autor:
Allen K. Bourdon, Giovanna Maria Spano, William Marshall, Michele Bellesi, Giulio Tononi, Pier Andrea Serra, Helen A. Baghdoyan, Ralph Lydic, Shawn R. Campagna, Chiara Cirelli
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
Abstract By identifying endogenous molecules in brain extracellular fluid metabolomics can provide insight into the regulatory mechanisms and functions of sleep. Here we studied how the cortical metabolome changes during sleep, sleep deprivation and
Externí odkaz:
https://doaj.org/article/a457f0f7191f427aa96a87048d92199f
Autor:
Brooke N. Dulka, Allen K. Bourdon, Catherine T. Clinard, Mohan B.K. Muvvala, Shawn R. Campagna, Matthew A. Cooper
Publikováno v:
Neurobiology of Stress, Vol 7, Iss , Pp 103-112 (2017)
Acute social defeat represents a naturalistic form of conditioned fear and is an excellent model in which to investigate the biological basis of stress resilience. While there is growing interest in identifying biomarkers of stress resilience, until
Externí odkaz:
https://doaj.org/article/7700218beeb344dd86f15311ae1fbdc1
Thiazolidinedione (TZD) drugs (Takeda Pharmaceuticals and Metabolic Solutions Development Company) targeting inhibition of the mitochondrial pyruvate carrier (MPC) are currently being tested in clinical trials to prevent progression into mild cogniti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b277d95514a08e47b73807b34b1f11
https://doi.org/10.4018/978-1-7998-3441-0.ch021
https://doi.org/10.4018/978-1-7998-3441-0.ch021
The mitochondrial pyruvate carrier (MPC) is a novel target for therapeutic drugs to treat Alzheimer's and Parkinson's disease, diabetes mellitus, and non-alcoholic steatohepatitis (NASH). Metabolic Solutions Development Company (MSDC) has two thiazol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18bb75f1dfa9a269268bc309b45ddf98
https://doi.org/10.4018/978-1-7998-3441-0.ch022
https://doi.org/10.4018/978-1-7998-3441-0.ch022
Autor:
Allen K. Bourdon, Brooke N. Dulka
Publikováno v:
Neuromethods ISBN: 9781071608630
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3311551050e1f6ac3728e44902a91dc7
https://doi.org/10.1007/978-1-0716-0864-7_5
https://doi.org/10.1007/978-1-0716-0864-7_5
Publikováno v:
ACS Chemical Neuroscience
Fourteen glucose transporters (GLUTs) play essential roles in human physiology by facilitating glucose diffusion across the cell membrane. Due to its central role in the energy metabolism of the central nervous system, GLUT3 has been thoroughly inves
Autor:
Po Hsiang Wang, Burcu Şimşir, Yongchao Yin, Elizabeth A. Edwards, Abigail T. Farmer, Yi Yang, Shawn R. Campagna, Olivia Molenda, Nannan Jiang, Andrew T. Quaile, Allen K. Bourdon, Jun Yan, Frank E. Löffler, Meng Bi
Publikováno v:
Nature chemical biology
Cobamides such as vitamin B12 are structurally conserved, cobalt-containing tetrapyrrole biomolecules that have essential biochemical functions in all domains of life. In organohalide respiration, a vital biological process for the global cycling of
Autor:
Catherine T. Clinard, Allen K. Bourdon, Brooke N. Dulka, Mohan B.K. Muvvala, Matthew A. Cooper, Shawn R. Campagna
Publikováno v:
Neurobiology of Stress
Neurobiology of Stress, Vol 7, Iss, Pp 103-112 (2017)
Neurobiology of Stress, Vol 7, Iss, Pp 103-112 (2017)
Acute social defeat represents a naturalistic form of conditioned fear and is an excellent model in which to investigate the biological basis of stress resilience. While there is growing interest in identifying biomarkers of stress resilience, until
Publikováno v:
International Journal of Knowledge Discovery in Bioinformatics. 7:43-67
The mitochondrial pyruvate carrier (MPC) is a novel target for therapeutic drugs to treat Alzheimer's and Parkinson's disease, diabetes mellitus, and non-alcoholic steatohepatitis (NASH). Metabolic Solutions Development Company (MSDC) has two thiazol
Publikováno v:
International Journal of Knowledge Discovery in Bioinformatics. 7:68-82
Thiazolidinedione (TZD) drugs (Takeda Pharmaceuticals and Metabolic Solutions Development Company) targeting inhibition of the mitochondrial pyruvate carrier (MPC) are currently being tested in clinical trials to prevent progression into mild cogniti